• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Assessing uptake of the Harmonising Outcome Measures for Eczema (HOME) Core Outcome Set and recommended instruments.

作者信息

Vincent R, Chalmers J R, McWilliams C, Thomas K S, Dodd S, Rogers N, Ridd M J, Schmitt J, Kirkham J J

机构信息

University Hospital Bristol NHS Foundation Trust, UK.

Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK.

出版信息

Br J Dermatol. 2020 Sep;183(3):566-568. doi: 10.1111/bjd.19030. Epub 2020 May 10.

DOI:10.1111/bjd.19030
PMID:32167583
Abstract
摘要

相似文献

1
Assessing uptake of the Harmonising Outcome Measures for Eczema (HOME) Core Outcome Set and recommended instruments.评估湿疹统一结局测量指标（HOME）核心结局集及推荐工具的采用情况。
Br J Dermatol. 2020 Sep;183(3):566-568. doi: 10.1111/bjd.19030. Epub 2020 May 10.
2
Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review.特应性皮炎症状测量工具的测量特性评估：系统评价。
Allergy. 2017 Jan;72(1):146-163. doi: 10.1111/all.12959. Epub 2016 Jul 13.
3
Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative.在临床实践中测量特应性皮炎症状：来自特应性皮炎临床实践中协调结局测量倡议的第一份共识声明。
J Am Acad Dermatol. 2020 May;82(5):1181-1186. doi: 10.1016/j.jaad.2019.12.055. Epub 2020 Jan 8.
4
Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany.特应性皮炎结局指标协调（HOME）。第一次国际共识会议（HOME1）报告，2010 年 7 月 24 日，德国慕尼黑。
Br J Dermatol. 2010 Dec;163(6):1166-8. doi: 10.1111/j.1365-2133.2010.10054.x.
5
Standardized reporting of the Eczema Area and Severity Index (EASI) and the Patient-Oriented Eczema Measure (POEM): a recommendation by the Harmonising Outcome Measures for Eczema (HOME) Initiative.湿疹面积和严重程度指数（EASI）及患者导向性湿疹评估（POEM）的标准化报告：湿疹统一结局测量（HOME）倡议的一项建议
Br J Dermatol. 2018 Aug;179(2):540-541. doi: 10.1111/bjd.16732. Epub 2018 Jun 25.
6
Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.患者导向湿疹测量表（POEM），一种用于临床试验中测量症状的核心工具：特应性皮炎结局测量指标协调（HOME）声明。
Br J Dermatol. 2017 Apr;176(4):979-984. doi: 10.1111/bjd.15179. Epub 2017 Mar 2.
7
What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 3: nomenclature and outcome assessment.特应性皮炎的新进展？2016 年发表的系统评价分析。第 3 部分：命名法和结局评估。
Clin Exp Dermatol. 2019 Jun;44(4):376-380. doi: 10.1111/ced.13886. Epub 2019 Jan 31.
8
IDQoL, CDLQI and the 45-item CADIS received a sufficient content validity rating during the HOME VII meeting in Japan: a group discussion study.在日本举行的第七届居家会议期间，IDQoL、CDLQI以及包含45个条目的CADIS通过一项小组讨论研究获得了足够的内容效度评级。
J Eur Acad Dermatol Venereol. 2021 Feb;35(2):458-463. doi: 10.1111/jdv.16848. Epub 2020 Aug 17.
9
Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).特应性皮炎临床试验协调核心结局指标的第四次国际共识会议报告（HOME 倡议）。
Br J Dermatol. 2016 Jul;175(1):69-79. doi: 10.1111/bjd.14773. Epub 2016 Jul 19.
10
Reaching clinically relevant outcome measures for new pharmacotherapy and immunotherapy of atopic eczema.为特应性皮炎的新药物疗法和免疫疗法达成具有临床相关性的疗效指标。
Curr Opin Allergy Clin Immunol. 2015 Jun;15(3):227-33. doi: 10.1097/ACI.0000000000000158.

引用本文的文献

1
Measuring the success of programmes of care for people living with dementia: a protocol for consensus building with consumers to develop a set of Core Outcome Measures for Improving Care (COM-IC).衡量痴呆症患者护理计划的成效：与消费者达成共识以制定一套改善护理的核心结局测量指标（COM-IC）的方案。
BMJ Open. 2023 Dec 10;13(12):e073884. doi: 10.1136/bmjopen-2023-073884.
2
Implementation of the HOME core outcome set for clinical trials of atopic eczema-barriers and opportunities: the HOME IX meeting report.特应性皮炎临床试验中实施 HOME 核心结局集的障碍和机遇：HOMEIX 会议报告。
Arch Dermatol Res. 2023 Nov;315(9):2617-2622. doi: 10.1007/s00403-023-02647-w. Epub 2023 Jul 11.
3
Consensus on the therapeutic management of atopic dermatitis ‒ Brazilian Society of Dermatology: an update on phototherapy and systemic therapy using e-Delphi technique.
特应性皮炎治疗管理的共识——巴西皮肤病学会：利用电子德尔菲技术更新光疗和系统治疗。
An Bras Dermatol. 2023 Nov-Dec;98(6):814-836. doi: 10.1016/j.abd.2023.04.003. Epub 2023 Jun 9.
4
Establishment and Utility of SwedAD: A Nationwide Swedish Registry for Patients with Atopic Dermatitis Receiving Systemic Pharmacotherapy.SwedAD 的建立与应用：一个全国性的瑞典特应性皮炎系统药物治疗患者登记处。
Acta Derm Venereol. 2023 Apr 6;103:adv7312. doi: 10.2340/actadv.v103.7312.
5
Frequency and influence of "not relevant" responses on the Dermatology Life Quality Index among adults with atopic dermatitis.“不相关”回答对成人特应性皮炎患者皮肤病生活质量指数的频率及影响
Qual Life Res. 2021 Jun;30(6):1705-1713. doi: 10.1007/s11136-021-02770-z. Epub 2021 Feb 4.
6
Identifying and appraising patient-reported outcome measures on treatment satisfaction in acne: a systematic review.识别和评价痤疮治疗满意度的患者报告结局测量指标：系统评价。
Br J Dermatol. 2021 Jul;185(1):36-51. doi: 10.1111/bjd.19675. Epub 2020 Dec 28.
7
A systematic review finds Core Outcome Set uptake varies widely across different areas of health.一项系统评价发现，核心结局集在不同健康领域的采用情况差异很大。
J Clin Epidemiol. 2021 Jan;129:114-123. doi: 10.1016/j.jclinepi.2020.09.029. Epub 2020 Sep 26.